tiprankstipranks
Quantum Biopharma (QNTM)
NASDAQ:QNTM
US Market
QNTM
Quantum Biopharma
RESEARCH TOOLSreports

Quantum Biopharma (QNTM) Financial Statements

685 Followers

Quantum Biopharma Financial Overview

Quantum Biopharma's market cap is currently $26.28M. The company's EPS TTM is $-0.47238182400000006; its P/E ratio is -0.57; Quantum Biopharma is scheduled to report earnings on August 13, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Aug 17
Income Statement
Total Revenue
Gross Profit-----
Operating Income$ -19.23M$ -27.48M$ -33.81M$ -30.69M$ -19.37K
EBITDA-$ -22.57M$ -29.09M$ -24.46M$ -19.37K
Net Income$ -17.90M$ -23.61M$ -35.29M$ -31.80M$ -19.37K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 17.47M$ 38.41M$ 62.96M$ 41.97M$ 17.69K
Total Debt$ 339.20K$ 516.42K$ 555.90K$ 510.61K$ 35.00K
Net Debt$ -3.17M$ -16.46M$ -34.86M$ -17.01M$ 17.31K
Total Liabilities$ 4.57M$ 7.87M$ 9.22M$ 6.02M$ 113.22K
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -10.83M$ -29.10M$ -21.25M$ -19.13M$ -21.11K
Operating Cash Flow$ -10.83M$ -28.33M$ -20.75M$ -19.13M$ -21.11K
Investing Cash Flow
Financing Cash Flow

Quantum Biopharma Earnings and Revenue History

Income Statement >

Quantum Biopharma Debt to Assets

Balance Sheet >

Quantum Biopharma Cash Flow

Cash Flow >

Quantum Biopharma Forecast EPS vs Actual EPS

Earnings >